Literature DB >> 31630050

Thelaziosis due to Thelazia callipaeda in Europe in the 21st century-A review.

Beatriz do Vale1, Ana Patrícia Lopes2, Maria da Conceição Fontes2, Mário Silvestre3, Luís Cardoso4, Ana Cláudia Coelho2.   

Abstract

Thelazia callipaeda was first described at the beginning of the 20th century in Asia, but this eyeworm is now frequently reported in Europe in the 21st century. To date, thelaziosis has been described in the following European countries (in order of appearance): Italy, France, Germany, Switzerland, Spain, Portugal, Belgium, Bosnia and Herzegovina, Croatia, Serbia, Romania, Greece, Bulgaria, Hungary, Slovakia, the United Kingdom, Turkey and Austria. The infected vertebrate host species include domestic carnivores (dogs and cats), wild carnivores (red foxes, wolves, beech martens, wildcats and golden jackals), lagomorphs (brown hares and wild European rabbits) and humans. In Europe, 11 cases of human thelaziosis have been reported, the majority of which are autochthonous. However, some of them have been imported, a fact which highlights the importance of surveillance policies to restrict cross-border spread of the parasite. The objectives of this article are to review key aspects of the epidemiology of T. callipaeda, summarise animal and human cases in Europe and emphasise the importance of education and awareness among veterinarians, physicians (particularly ophthalmologists) and animal, in order to owners to tackle this zoonosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cat; Dog; Human; Phortica variegata; Red fox; Thelazia callipaeda; Zoonosis

Mesh:

Year:  2019        PMID: 31630050     DOI: 10.1016/j.vetpar.2019.108957

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  7 in total

1.  The Vector-Borne Zoonotic Nematode Thelazia callipaeda in the Eastern Part of Europe, with a Clinical Case Report in a Dog in Poland.

Authors:  Leszek Rolbiecki; Joanna N Izdebska; Marta Franke; Lech Iliszko; Sławomira Fryderyk
Journal:  Pathogens       Date:  2021-01-09

2.  Ocular thelaziosis: A case report of an emerging zoonosis.

Authors:  Marta Isabel Martínez-Sánchez; Gema Bolívar-de-Miguel; Juan Cuadros-González; José Miguel Rubio González
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-25

3.  Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio®) for the prevention of Thelazia callipaeda canine eyeworm infection.

Authors:  Marcos Antonio Bezerra-Santos; Jairo Alfonso Mendoza-Roldan; Giovanni Sgroi; Riccardo Paolo Lia; Giulia Venegoni; Fabrizio Solari Basano; Roose Nele; Sean P Mahabir; Stasia Borowski; Thomas Geurden; Domenico Otranto
Journal:  Parasit Vectors       Date:  2022-10-16       Impact factor: 4.047

4.  Systematic review on infection and disease caused by Thelazia callipaeda in Europe: 2001-2020.

Authors:  Beatriz do Vale; Ana Patrícia Lopes; Maria da Conceição Fontes; Mário Silvestre; Luís Cardoso; Ana Cláudia Coelho
Journal:  Parasite       Date:  2020-09-29       Impact factor: 3.000

5.  Suspected autochthonous Thelazia callipaeda infection in a dog in northern Germany.

Authors:  Sophia L Lebedewa; Kevin Tkocz; Peter-Henning Clausen; Ard M Nijhof
Journal:  Parasitol Res       Date:  2020-10-13       Impact factor: 2.289

6.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

7.  Efficacy of fipronil/(S)-methoprene/eprinomectin/praziquantel (Broadline®) against Thelazia callipaeda in naturally infected cats.

Authors:  Stefania Zanet; Simone Morelli; Angela Di Cesare; Stefano Bò; Donato Traversa; Wilfried Lebon; Frederic Beugnet; Giulia Simonato; Ezio Ferroglio
Journal:  Parasit Vectors       Date:  2021-09-15       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.